| Code | CSB-RA023978MB3HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to BITR-2101, designed to specifically recognize TNFRSF1B (Tumor Necrosis Factor Receptor Superfamily Member 1B), also known as TNFR2 or CD120b. TNFRSF1B is a cell surface receptor that binds tumor necrosis factor-alpha (TNF-α) and plays a crucial role in regulating immune responses, cell survival, and inflammation. Unlike TNFRSF1A, which primarily mediates pro-inflammatory and apoptotic signaling, TNFRSF1B predominantly activates pro-survival pathways and modulates T regulatory cell function. This receptor is implicated in various pathological conditions including autoimmune diseases, chronic inflammatory disorders, cancer progression, and neurodegenerative diseases.
BITR-2101 has been utilized in research to investigate TNFRSF1B-mediated signaling pathways and its role in immune regulation. This biosimilar antibody provides researchers with a reliable tool for studying TNF-α receptor biology, exploring therapeutic targets in inflammatory and malignant diseases, and investigating the differential functions of TNF receptor subtypes in various cellular contexts.
There are currently no reviews for this product.